Sumitomo Dainippon Pharma Co. Ltd. and Poxel SA announced the signing of a strategic partnership for the development and commercialization of Imeglimin – an investigational therapeutic agent for type 2 diabetes – in Japan, China, South Korea, Taiwan and nine other Southeast Asian countries. Poxel is a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders.
Outcome Health announced a partnership with Navicent Health. The partnership will bring the Outcome Health platform to Navicent Health Physicians Group, which includes over 100 active physicians and their medical/surgical practices.
The theory and practice of overturning marketing conventions.
The membership of the Medical Advertising Hall of Fame elected Robert Leverte as its 2018 inductee. Leverte’s career included founding ERS – an in-house ad agency at ER Squibb – co-founding Ruvane-Leverte advertising, Chairman at Bozell Jacobs Medical Group and CEO of the Leverte Companies.
The HBA is pleased to announce a new three-part webinar series, Accelerating Gender Intelligence.
Janssen-Cilag International NV announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use recommended broadening the existing marketing authorization for Zytiga (abiraterone acetate) plus prednisone/prednisolone to include an earlier stage of prostate cancer than its current indications.
For this annual special report, which is in its 31st year of publication, Med Ad News editors rank and profile the world’s top 50 companies that generate revenue from healthcare products.
For the pharmaceutical industry, 2016 brought new blockbusters onto the market to ease the pain of patent expirations.
The healthcare advertising industry’s next generation of leaders, guided by those who have already made it to the top, gathered at the Medical Advertising Hall of Fame’s View From The Top event.
While the world’s leading prescription drug Humira still accounts for the majority of AbbVie’s revenue, plenty else is bubbling up at the almost-five-year-old company.